Related Experiment Video
Updated: Jun 6, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Dysregulated Coagulation in Parkinson's Disease
Xinqing Wang1, Wenxin Li2, Xinyue Zhao2
1School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China.
Parkinson's disease (PD) is linked to blood clotting issues, with PD patients showing higher risks of thrombosis. Understanding this connection may reveal new treatments for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Hematology
Background:
- Parkinson's disease (PD) involves neurodegeneration and alpha-synuclein buildup.
- Coagulation dysfunction is increasingly recognized as a factor in PD.
Purpose of the Study:
- To review emerging evidence linking coagulation dysregulation to PD pathophysiology.
- To explore potential mechanisms and future research directions.
Main Methods:
- Synthesis of current research on coagulation parameters in PD.
- Examination of epidemiological data on thrombotic events in PD patients.
- Analysis of the roles of inflammation and oxidative stress.
Main Results:
- PD patients exhibit altered coagulation: elevated fibrinogen, impaired fibrinolysis, and platelet dysfunction.
- A hypercoagulable state is observed in PD.
- Increased incidence of deep vein thrombosis (DVT) and stroke in PD patients.
Conclusions:
- Dysregulated coagulation is significantly associated with Parkinson's disease.
- Inflammation and oxidative stress may mediate the link between coagulation and neurodegeneration.
- Further research into the coagulation-neurodegeneration axis is crucial for novel PD diagnostics and therapeutics.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Neural Regulation
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

